[공지사항]을 빙자한 안부와 근황 
Show more

Daily Arxiv

This is a page that curates AI-related papers published worldwide.
All content here is summarized using Google Gemini and operated on a non-profit basis.
Copyright for each paper belongs to the authors and their institutions; please make sure to credit the source when sharing.

MedSR-Impact: Transformer-Based Super-Resolution for Lung CT Segmentation, Radiomics, Classification, and Prognosis

Created by
  • Haebom

Author

Marc Boubnovski Martell, Kristofer Linton-Reid, Mitchell Chen, Sumeet Hindocha, Benjamin Hunter, Marco A. Calzado, Richard Lee, Joram M. Posma, Eric O. Aboagye

Outline

Transformer Volumetric Super-Resolution Network (TVSRN-V2) is a Transformer-based super-resolution (SR) framework designed to enhance the resolution of low-dose chest CT. Built with scalable components including Through-Plane Attention Blocks (TAB) and Swin Transformer V2, it effectively reconstructs fine anatomical details from low-dose CT and integrates seamlessly with downstream analysis pipelines. Its performance is evaluated in various clinical cohorts for three clinical tasks: lung cancer lobe segmentation, radiomics genomics, and prognosis prediction, and a virtual low-resolution augmentation technique that does not require personal information is introduced to increase the robustness to various acquisition protocols.

Takeaways, Limitations

Takeaways:
Effectively reconstructs fine anatomical details in low-dose CT to improve the accuracy of diagnosis and treatment planning.
It shows improved leaf segmentation accuracy (+4% Dice), improved radiomics feature reproducibility, and improved prediction performance (+0.06 C-index and AUC).
It is established as a clinically viable system for dose-efficient imaging and quantitative analysis in real-world CT workflows.
Improves robustness to various scanner protocols through virtual low-resolution augmentation techniques.
Limitations:
The specific Limitations is not explicitly mentioned in the paper. Additional research may be needed.
Additional validation may be needed for clinical applications.
Further studies may be needed to determine generalizability across different lung diseases.
👍